## **Core Concept**
5-Fluorouracil (5-FU) is a chemotherapeutic agent used in the treatment of various cancers, including colorectal, breast, and skin cancers. It belongs to the class of antimetabolites, which interfere with DNA and RNA synthesis. The primary mechanism of action of 5-FU involves the inhibition of thymidylate synthase.

## **Why the Correct Answer is Right**
The correct answer, **Thymidylate Synthase**, is the target enzyme for 5-Fluorouracil. 5-FU is converted into 5-fluoro-2'-deoxyuridylate (FdUMP), which is a potent inhibitor of thymidylate synthase. Thymidylate synthase is crucial for the synthesis of thymidine, a nucleotide required for DNA replication and repair. By inhibiting thymidylate synthase, 5-FU depletes the intracellular pool of thymidine, thereby inhibiting DNA synthesis and cell division, particularly in rapidly dividing cancer cells.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While dihydrofolate reductase is an important enzyme in the folate pathway and is targeted by other chemotherapeutic agents (e.g., methotrexate), it is not the primary target of 5-Fluorouracil.
- **Option B:** Ribonucleotide reductase is involved in the synthesis of deoxyribonucleotides, but 5-FU's primary mechanism does not involve the direct inhibition of this enzyme.
- **Option D:** DNA polymerase is crucial for DNA replication and repair, but 5-FU's anticancer action is more specifically related to the inhibition of thymidylate synthase rather than a direct effect on DNA polymerase.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that 5-Fluorouracil's efficacy can be enhanced by leucovorin, which is a form of folate. Leucovorin increases the stability of the ternary complex formed by FdUMP, thymidylate synthase, and leucovorin, thereby enhancing the inhibition of thymidylate synthase. This combination is commonly used in the treatment of colorectal cancer.

## **Correct Answer:** . Thymidylate Synthase